Two TV features in one weekend<\/h2>\n
This past weekend, two NBC affiliates shined a spotlight on how athletes and researchers are using the Vielight Neuro to support brain performance and recovery.<\/p>\n
- \n
- \n
KSL-TV 5<\/a> (Salt Lake City, UT)<\/strong> aired a section focusing on an inside look at the Vielight Neuro, which BYU Football athletes are finding success with this season, focusing on Vielight’s patented intranasal-transcranial PBM\u2019s role in performance and recovery, along with their breakout year.<\/p>\n<\/li>\n
- KCRA 3<\/a> (Sacramento, CA)<\/strong> profiled former Oregon State linebacker Rico Petrini Jr.<\/strong>, who participated in the University of Utah\u2019s photobiomodulation study. Petrini shared that he\u2019s experienced \u201cabout 80-90% improvement\u201d and is \u201cin the best place [he\u2019s] been in 20 years,\u201d while the station also noted BYU\u2019s team-wide use of the technology and that two NFL teams are evaluating it.<\/li>\n<\/ul>\n<\/div><\/div><\/div>
<\/lite-youtube><\/div><\/div><\/div><\/div> <\/lite-youtube><\/div><\/div><\/div><\/div><\/div><\/div> Third Feature: CBS Sacramento<\/h2>\n
CBS News<\/a> (Sacramento)<\/strong> featured former pro football player Rico Petrini Jr.<\/a> and his journey with Vielight brain photobiomodulation therapy after years of hits on the field. This summer, University of Utah researchers published phase two of their TBI clinical study (n=44)<\/a> using transcranial + intranasal photobiomodulation (itPBM) with Vielight technology over 8\u201310 weeks. This builds on their previous published itPBM TBI study (n=49).<\/p>\n<\/div><\/div><\/div>
<\/lite-youtube><\/div><\/div><\/div><\/div><\/div><\/div> From recovery to performance: why this matters<\/h2>\n
Independent coverage is catching up with what researchers and athletes have been exploring for years: transcranial-intranasal photobiomodulation (tPBM)<\/strong> can modulate brain activity and may support functional outcomes that matter on and off the field.<\/p>\n
- \n
- \n
In 2019, a randomized, double-blind, sham-controlled<\/strong> study published in Scientific Reports<\/em> showed that a single 20-minute session with the Vielight Neuro Gamma increased alpha\/beta\/gamma power, decreased delta\/theta, and altered functional connectivity and graph-theory network measures<\/strong> in healthy older adults, direct evidence of non-invasive neuromodulation. Nature<\/span><\/span><\/span><\/a><\/span><\/span><\/p>\n<\/li>\n
- \n
At the University of Utah<\/strong>, studies with collision athletes have reported consistent improvements on objective measures<\/strong> (e.g., processing speed\/strength) after at-home tPBM use, with ongoing clinical research underway.
\nPhase 1 –\u00a0Vielight Uni of Utah TBI Study<\/a> Cognitive test battery (e.g., CVLT-3, D-KEFS, CPT-3, NIH Toolbox).
\nPhase 2 – Vielight Uni of Utah TBI Study<\/a>\u00a0 Motor\/functional measures (reaction time drop test, Grooved Pegboard, grip dynamometer, MiniBEST.<\/p>\n<\/li>\n<\/ul>\n - \n
- KCRA 3<\/a> (Sacramento, CA)<\/strong> profiled former Oregon State linebacker Rico Petrini Jr.<\/strong>, who participated in the University of Utah\u2019s photobiomodulation study. Petrini shared that he\u2019s experienced \u201cabout 80-90% improvement\u201d and is \u201cin the best place [he\u2019s] been in 20 years,\u201d while the station also noted BYU\u2019s team-wide use of the technology and that two NFL teams are evaluating it.<\/li>\n<\/ul>\n<\/div><\/div><\/div>
![\"\"](\"https:\/\/www.vielight.com\/wp-content\/uploads\/2025\/08\/Tom-Holmoe.jpg\")
![\"\"](\"https:\/\/www.vielight.com\/wp-content\/uploads\/2025\/08\/Tom-Holmoe-2.png\")
<\/p>\n![\"\"](\"https:\/\/www.vielight.com\/wp-content\/uploads\/2025\/08\/DTI-Imaging-Utah-v1.jpg\")